App-Quantinova.ai

Left ventricular strain and dyssynchrony by CMR Feature tracking in Idiopathic Pulmonary Arterial Hypertension(IPAH)

Geeshath Jayasekera - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

N/A

Macitentan for inoperable chronic thromboembolic pulmonary hypertension (CTEPH): results from the randomised controlled MERIT study

Grald Simonneau - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Chronic thromboembolic pulmonary hypertension

macitentan

Prognostic relevance of right atrial function in pulmonary arterial hypertension

Michele D'Alto - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

N/A

Pulmonary arterial hypertension-related morbidity is prognostic for survival: insights from the SERAPHIN and GRIPHON studies

Marius M. Hoeper - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

N/A

Using controlled and real-world data in concert to assess survival benefits in pulmonary arterial hypertension: Insights from SERAPHIN and REVEAL

Raymond Benza - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

macitentan

Effect of riociguat on pulmonary arterial compliance in patients with pulmonary arterial hypertension (PAH) in the RESPITE study

Marius M. Hoeper - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

Riociguat

RISE-IIP: Riociguat for the treatment of pulmonary hypertension associated with idiopathic interstitial pneumonia

Steven Nathan - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic interstitial pneumonias

Riociguat

A pilot project to improve pulmonary rehabilitation adherence and outcomes in the COPD population: Glasgow City’s Community Respiratory Team

Rosie Meharry - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Home-based pulmonary rehabilitation reduces admissions for respiratory exacerbations and increases quality of life in MRC 5 group

Ismet Boral - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Depression

N/A

“When you’re at work you’ve got a goal [..] but that’s all finished for me now”; exploring goal perception amongst people with chronic obstructive pulmonary disease (COPD)

Rachael Summers - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Cross-sectional characteristics of individuals with mild-moderate COPD reporting contrasting self-reported symptom burden

Mark Orme - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

PAVAR goal setting improves health outcomes in a multidisciplinary community respiratory team

Marianne Milligan - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

Does pulmonary rehabilitation improve mortality in patients with chronic obstructive pulmonary disease (COPD)?

Gillian Mcvay - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Does Pulmonary Rehabilitation improve people’s experience of living with Chronic Obstructive Pulmonary Disease? A Retrospective Case Note Review

Laura Graham - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Can a 6 week multi-disciplinary weekend Pulmonary Rehabilitation service for patients with weekday work commitments be both feasible and effective?

Jide Owolabi - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Depression

N/A

Involvement of STAT-3 in the Beneficial Effects of Aerobic Exercise in a Model of Smoke-Induced COPD

Maysa Rangel - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

Interleukin-10

Integration of Hospital and Community Respiratory teams reduces admissions, shortens length of stay and improves patient care in COPD

Michael Apps - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Exploration of patients' and informal caregivers' experiences in advanced chronic obstructive pulmonary disease: first phase of an action research study

Tanja Fusi-Schmidhauser - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Dance as a rehabilitative strategy for patients with COPD

Victoria MacBean - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Palliative and end of life care conversations in COPD - a systematic literature review

Nuno Tavares - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Filters

45280 Abstracts